Victory Capital Management Inc. Has $2.38 Million Stake in Teleflex Incorporated (TFX)
Victory Capital Management Inc. lifted its position in Teleflex Incorporated (NYSE:TFX) by 12.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,555 shares of the medical technology company’s stock after acquiring an additional 1,067 shares during the period. Victory Capital Management Inc.’s holdings in Teleflex were worth $2,377,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also recently modified their holdings of the company. American Century Companies Inc. lifted its position in Teleflex by 41.6% during the third quarter. American Century Companies Inc. now owns 1,187,909 shares of the medical technology company’s stock worth $287,438,000 after buying an additional 348,829 shares in the last quarter. Principal Financial Group Inc. lifted its position in Teleflex by 0.8% during the third quarter. Principal Financial Group Inc. now owns 615,382 shares of the medical technology company’s stock worth $148,905,000 after buying an additional 4,984 shares in the last quarter. Frontier Capital Management Co. LLC lifted its position in Teleflex by 1.3% during the third quarter. Frontier Capital Management Co. LLC now owns 308,622 shares of the medical technology company’s stock worth $74,677,000 after buying an additional 4,077 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its position in Teleflex by 2.8% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 180,172 shares of the medical technology company’s stock worth $44,831,000 after buying an additional 4,903 shares in the last quarter. Finally, Swiss National Bank raised its position in Teleflex by 1.2% in the third quarter. Swiss National Bank now owns 165,600 shares of the medical technology company’s stock valued at $40,070,000 after purchasing an additional 2,000 shares during the period. 90.75% of the stock is currently owned by hedge funds and other institutional investors.
In related news, Director George Babich, Jr. sold 2,500 shares of the business’s stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $263.38, for a total transaction of $658,450.00. Following the completion of the transaction, the director now directly owns 10,583 shares of the company’s stock, valued at approximately $2,787,350.54. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP John Deren sold 1,359 shares of the business’s stock in a transaction on Wednesday, February 28th. The stock was sold at an average price of $255.67, for a total value of $347,455.53. The disclosure for this sale can be found here. Insiders sold a total of 14,259 shares of company stock worth $3,760,536 in the last quarter. Company insiders own 2.39% of the company’s stock.
Shares of Teleflex Incorporated (NYSE TFX) opened at $265.93 on Friday. The company has a quick ratio of 1.51, a current ratio of 2.33 and a debt-to-equity ratio of 0.89. The stock has a market capitalization of $11,980.00, a price-to-earnings ratio of 46.74, a P/E/G ratio of 1.97 and a beta of 1.22. Teleflex Incorporated has a 1-year low of $191.04 and a 1-year high of $288.78.
Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $2.44 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.40 by $0.04. The firm had revenue of $595.10 million for the quarter, compared to the consensus estimate of $601.17 million. Teleflex had a return on equity of 16.46% and a net margin of 7.11%. The company’s quarterly revenue was up 15.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.13 EPS. research analysts forecast that Teleflex Incorporated will post 9.68 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 15th. Investors of record on Friday, March 2nd were issued a $0.34 dividend. The ex-dividend date of this dividend was Thursday, March 1st. This represents a $1.36 annualized dividend and a dividend yield of 0.51%. Teleflex’s dividend payout ratio is presently 23.90%.
TRADEMARK VIOLATION NOTICE: This story was first published by Marea Informative and is the property of of Marea Informative. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://www.mareainformativa.com/2018/03/16/teleflex-incorporated-tfx-shares-bought-by-victory-capital-management-inc-updated-updated-updated.html.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.